Skip to content
Homepage
Author:
Colossal Biosciences Inc.
Posted Date:
June 30, 2026
Colossal Foundation and University of Tasmania Partner to Combat Devil Facial Tumour Disease with Vaccines and Gene Editing
Colossal Biosciences Inc.
June 30, 2026
Colossal Biosciences and U.S. Fish and Wildlife Service Launch Landmark BioVault Initiative for Every ESA-Listed Species
Colossal Biosciences Inc.
June 25, 2026
Colossal Biosciences Hatches First Chicks from Its Fully Artificial Egg System
Colossal Biosciences Inc.
May 19, 2026
Colossal Biosciences Expands De-extinction Portfolio with Iconic Bluebuck
Colossal Biosciences Inc.
April 30, 2026
